HMIRC Notices - Decisions and Orders

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

December 27, 2008

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	MSDS Preparation Date (As shown on the MSDS)	Date of Decision
Cytec Industries Inc., West Paterson, New Jersey	CYCOMÒ 97714A/ Carbon Prepreg	6229	07/08/2005	July 31, 2008
3M Canada Company, London, Ontario	SCOTCHCAL BRAND HIGH PERFORMANCE INK, 7922, BLUE	6236	21/07/2005	July 3, 2008
3M Canada Company, London, Ontario	3M(TM) BRAND SUPER TRIM ADHESIVE P/N 08090	6284	2007/10/31	June 18, 2008
BYK-Chemie USA Inc., Wallingford, Connecticut	Disperbyk-112	6419	02/23/2006	August 29, 2008
Cytec Industries Inc., West Paterson, New Jersey	CYCOMÒ 7277 Glass Prepreg	6421	01/17/2006	July 31, 2008
Enthone Inc., West Haven, Connecticut	BLACK PEARLÒ ADJUSTER	6427	4/20/2007	August 28, 2008
Enthone Inc., West Haven, Connecticut	BLACK PEARLÒ MAINTENENCE	6428	4/20/2007	August 28, 2008
Enthone Inc., West Haven, Connecticut	SOLDEREXÒ TB-A	6456	4/23/2007	July 10, 2008
Enthone Inc., West Haven, Connecticut	RHODEXÒ BRIGHT RHODIUM CONCENTRATE	6459	4/23/2007	September 9, 2008
3M Canada Company, London, Ontario	3M(TM) SCREEN PRINTING UV INK SERIES 9800CL SCREEN PRINT CLEAR	6496	2007-06-27	July 14, 2008
Schlumberger Canada Limited, Calgary, Alberta	Sulfate Scale Dissolver U 104	6533	22 April 2008 (English) 22 avril 2008 (French)	September 9, 2008
Canyon Technical Services, Calgary, Alberta	CAN-1201	6535	May 23, 2008 (English) Le 23 mai 2008 (French) May 30, 2008 (date label in force)	June 6, 2008
Canyon Technical Services, Calgary, Alberta	CAN-1200	6536	May 23, 2008 (English) Le 23 mai 2008 (French) May 30, 2008 (date label in force)	June 24, 2008
Canyon Technical Services, Calgary, Alberta	CAN-1203	6537	May 23, 2008 (English) Le 23 mai 2008 (French) May 30, 2008 (date label in force)	June 24, 2008
GE Betz Canada Inc., Mississauga, Ontario	PROSHIELD 61N	6556	26-NOV-2007	July 7, 2008
GE Betz Canada Inc., Mississauga, Ontario	PROCHEM 2X31	6557	4-MAY-2006	July 9, 2008
GE Betz Canada Inc., Mississauga, Ontario	PROSWEET 0C2543	6559	03-JAN-2008	July 7, 2008
GE Betz Canada Inc., Mississauga, Ontario	PROCHEM 5K1643	6561	06-NOV-2007	June 30, 2008
Chevron Oronite Company LLC, Bellarie, Texas	OLOA 55417	6564	05/03/2006	July 22, 2008
Rohm and Haas Canada LP, West Hill, Ontario	ADCOTE (tm) 37R972	6579	02/15/2008	July 25, 2008
Rohm and Haas Canada LP, West Hill, Ontario	ADCOTE (TM) 37P295HV	6580	04/27/2006	July 25, 2008
Rohm and Haas Canada LP, West Hill, Ontario	ADCOTE (TM) 37R345	6581	04/27/2006	July 25, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) K-400 Processing Aid	6591	01/12/2007	August 25, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) K-415 Processing Aid	6592	04/27/2006	July 31, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) K-435L Processing Aid	6593	04/27/2006	July 31, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) KM-348 Impact Modifier	6595	04/27/2006	July 31, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) KM-342B Impact Modifier	6596	04/27/2006	July 31, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) 342B Powder	6599	06/01/2007	July 31, 2008
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID (TM) K-440L Processing Aid formerly PARALOID (TM) K-440 Processing Aid	6601	04/27/2006	August 25, 2008
Cognis Canada Corporation, Mississauga, Ontario	DSX 3515	6609	12/04/2007	July 3, 2008
Nalco Canada Co., Burlington, Ontario	FORTISÒ EC3056A formerly EC3056A	6614	2008/04/06	September 29, 2008
Nalco Canada Co., Burlington, Ontario	EC3081A	6615	2008/04/08	September 29, 2008
Nalco Canada Co., Burlington, Ontario	EC3264A formerly Prism EC3264A	6616	2008/04/06	September 29, 2008
Nalco Canada Co., Burlington, Ontario	FLEXSORB SE EC9016A	6619	2008/04/08	September 9, 2008
3M Canada Company, London, Ontario	SCOTCH-WELD (TM) AF-325 LS BLUE LOW DENSITY	6623	2006-11-17	August 12, 2008
3M Canada Company, London, Ontario	SCOTCH-WELD (TM) AF-325 BLUE LOW DENSITY	6624	2006-05-17	August 12, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTEÒ E-11 E	6628	05/04/2006	September 10, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	PETROÒ 11 POWDER formerly Petro (R) 11 Powder	6630	5/15/2006	July 29, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	PETROÒ BA POWDER formerly Petro (R) BA powder	6631	5/15/2006	July 29, 2008
GE Betz Canada Inc., Mississauga, Ontario	STYREX 3306	6647	27-JUL-2007	September 22, 2008
3M Canada Company, London, Ontario	SCOTCHWELD (TM) EC-3984 Structural Adhesive	6651	2006/06/22	September 30, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTEÒ E-64R E	6653	06/13/2006	September 10, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMEENÒ PF-1	6663	June 26, 2006	July 31, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMEENÒ PF-30	6664	June 26, 2006	July 31, 2008
Chevron Oronite Company LLC, Bellarie, Texas	OLOA 55419	6666	September 13, 2006	July 22, 2008
Acheson Colloids Company, Port Huron, Michigan	EMRALON 8370C	6671	3/08/2006 (English) 06/03/08 (French)	July 8, 2008
Acheson Colloids Company, Port Huron, Michigan	TW-035	6672	6/05/2008	September 12, 2008
Acheson Colloids Company, Port Huron, Michigan	Emralon 305	6681	4/18/2006 (English) 06/04/18 (French)	June 25, 2008
Acheson Colloids Company, Port Huron, Michigan	LUMIDAG EL-041	6684	3/29/2007 (English) 06/04/03 (French/)	July 8, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	BEROLÒ 563 SA formerly Berol 563SA	6695	7-19-2006	September 10, 2008
Chevron Oronite Company LLC, Bellarie, Texas	OLOA 1299W	6697	August 22, 2006	July 29, 2008
Hexion Specialty Chemicals Inc., Houston, Texas	EPIKURE™ 3290 Curing Agent	6698	06/02/2007	September 29, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	WITBREAK™ RTC 330 formerly Witbreak RTC 330	6716	9/29/2006	July 29, 2008
3M Canada Company, London, Ontario	SCOTCH-WELD(TM) EPOXY ADHESIVE DP-4XL-EG (PART A)	6717	2007/11/19	June 18, 2008
BYK-Chemie USA Inc., Wallingford, Connecticut	Anti-TerraÒ - U 100	6722	12/11/2007	September 22, 2008
Hexion Specialty Chemicals Inc., Houston, Texas	EPIKURE™ Curing Agent 6870-W-53	6729	06/03/2007	August 11, 2008
Baker Petrolite Corporation, Sugar Land, Texas	CGW3360 CORROSION INHIBITOR	6735	10/23/2006	September 29, 2008
Baker Petrolite Corporation, Sugar Land, Texas	CGW9994 CORROSION INHIBITOR	6736	10/23/2006	September 29, 2008
E. I. duPont Canada Company, Mississauga, Ontario	Dupont (TM) Cyrel (R) Cylosol Plate Washout Solution	6740	25-OCT-2006	September 22, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	BEROLÒ 505	6742	11/03/2006	June 30, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	BEROLÒ 508	6743	05/15/2007	June 30, 2008
Nalco Canada Co., Burlington, Ontario	CLASTA XP	6746	2008/06/23	August 26, 2008
Raybo Chemical Company, Huntington, West Virginia	RAYBO 82 ANTISTAT	6748	Oct31/07 (English) OCT31/07 (French)	August 11, 2008
Raybo Chemical Company, Huntington, West Virginia	RAYBO 41 SPANGLE	6749	Oct31/07 (English) OCT31/07 (French)	August 11, 2008
Cognis Canada Corporation, Mississauga, Ontario	PHOTOMER 5010 F	6767	02/07/2008	September 19, 2008
Cytec Industries Inc., West Paterson, New Jersey	BRÒ 127 Corrosion Inhibiting Primer, 10% Solids	6770	07/31/2006	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 377U Adhesive Film	6771	07/24/2006	August 28, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 377S Adhesive Film	6772	07/24/2006	August 28, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 490A Adhesive Foam	6774	11/21/2006	September 15, 2008
Cytec Industries Inc., West Paterson, New Jersey	CYCOMÒ 985 Aramid Fiber Structural Resin	6775	07/31/2006	September 15, 2008
Cytec Industries Inc., West Paterson, New Jersey	MX 2600 Bias Tape	6776	02/03/2006	August 28, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 284-N radiation curing resins	6778	11/16/2006	September 15, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 1259 radiation curing resins	6779	06/19/2008	September 29, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 8800 radiation curing resins	6780	06/19/2008	September 30, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 8803 radiation curing resins	6781	06/19/2008	September 30, 2008
Nalco Canada Co., Burlington, Ontario	NALCO(R) 8316	6783	2008/06/23	August 26, 2008
Cytec Industries Inc., West Paterson, New Jersey	HTÒ 424 Adhesive Film	6791	04/12/2007	September 12, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 1000 Adhesive Film	6792	02/22/2006	September 15, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 300 Adhesive Film	6793	06/12/2007	September 30, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 300-2 Adhesive Film	6794	04/12/2007	September 30, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 350 NA Adhesive Film	6795	12/18/2006	September 12, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 410 Core Splice Adhesive Foam	6797	12/18/2006	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 410-1 Adhesive Core Splice	6798	04/12/2007	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 1015 Adhesive Film	6799	12/18/2006	September 12, 2008
Cytec Industries Inc., West Paterson, New Jersey	FMÒ 1015-U Adhesive Film	6800	12/18/2006	September 12, 2008
MeadWestvaco Corporation, Covington, Virginia	NUCHARÒ WV-IS XL SPECIALTY TREATED ACTIVATED CARBON formerly Nuchar WV-IS XL Specialty Treated Activated Carbon	6809	12/15/2006	July 16, 2008
R. T. Vanderbilt Company Inc., Norwalk, Connecticut	VANLUBEÒ 672	6813	2/4/2008	July 8, 2008
BYK-Chemie USA Inc., Wallingford, Connecticut	Anti-Terra-203	6817	01/10/2007	September 22, 2008
Cognis Canada Corporation, Mississauga, Ontario	DEHYPOUND ADVANCED	6821	02/13/2008	September 19, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-0422 COLORTRENDÒ MAGENTA formerly AquatrendÒ Plus™ 870-0422 COLORTRENDÒ MAGENTA	6826	03/10/2008	September 30, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-0825 COLORTRENDÒ HIGH PERFORMANCE RED formerly AquatrendÒ Plus™ 870-0825 COLORTRENDÒ HIGH PERFORMANCE RED	6827	03/10/2008	September 30, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-0832 COLORTRENDÒ ORGANIC RED formerly AquatrendÒ Plus™ 870-0832 COLORTRENDÒ ORGANIC RED	6828	03/10/2008	September 30, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-0842 COLORTRENDÒ ORGANIC RED formerly AquatrendÒ Plus™ 870-0842 COLORTRENDÒ ORGANIC RED	6829	03/10/2008	September 30, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-1045 COLORTRENDÒ F RED OXIDE formerly AquatrendÒ Plus™ 870-1045 COLORTRENDÒ F RED OXIDE	6830	03/10/2008	September 30, 2008
Evonik Degussa Canada Inc., Brampton, Ontario	870-1572 COLORTRENDÒ I BROWN OXIDE formerly AquatrendÒ Plus™ 870-1572 COLORTRENDÒ I BROWN OXIDE	6831	03/10/2008	September 30, 2008
Chevron Products Company, Richmond, California	Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 418 (All)	6849	February 11, 2008	September 29, 2008
Chevron Products Company, Richmond, California	Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 422 (All)	6850	February 11, 2008	September 29, 2008
Chevron Products Company, Richmond, California	Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 424 (All)	6851	February 11, 2008	September 29, 2008
Lubrizol Corporation, Wickliffe, Ohio	IRCOGELÒ 905	6852	16 October 2007	September 4, 2008
Lubrizol Corporation, Wickliffe, Ohio	ANGLAMOLÒ 6043P	6853	16 October 2007	September 4, 2008
Lubrizol Corporation, Wickliffe, Ohio	ANGLAMOLÒ 9001N	6854	05 April 2007	September 4, 2008
Henkel Canada Corporation, Mississauga, Ontario	PARCOSOL 577 WB	6857	Feb25/08	August 7, 2008
Henkel Canada Corporation, Mississauga, Ontario	PARCOSOL 570 WB	6858	Feb25/08	August 7, 2008
Baker Petrolite Corporation, Sugar Land, Texas	CRW9124 CORROSION INHIBITOR	6859	1/12/2007	September 29, 2008
Nalco Canada Co., Burlington, Ontario	TST-602	6864	2008/06/10	August 19, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 8403 radiation curing resins	6871	06/19/2008	September 30, 2008
Nalco Canada Co., Burlington, Ontario	EC9092A Process Antifoulant	6887	2008/06/23	August 21, 2008
Chevron Oronite Company LLC, Bellarie, Texas	OLOA 55008	6890	February 12, 2007	July 22, 2008
Lubrizol Corporation, Wickliffe, Ohio	SOLSPERSEÒ 20000	6891	05 June 2007	July 30, 2008
Lubrizol Corporation, Wickliffe, Ohio	SOLSPERSEÒ 41000	6892	28 May 2008	July 30, 2008
Lubrizol Corporation, Wickliffe, Ohio	SOLSPERSEÒ 41090	6893	21 November 2007	July 30, 2008
Cytec Industries Inc., West Paterson, New Jersey	EBECRYLÒ 9312 radiation curing resins	6899	03/08/2007	September 30, 2008
Cognis Canada Corporation, Mississauga, Ontario	CAPCURE 40 SECHV	6900	02/23/2007	September 19, 2008
Henkel Canada Corporation, Mississauga, Ontario	P3 FORGE 4774	6927	Feb25/08	August 7, 2008
Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOLÒ 5782S	6950	03 January 2008	September 4, 2008
Cytec Industries Inc., West Paterson, New Jersey	BRÒ 227 Primer	6955	09/30/2005	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	BRÒ 227 Pour Coat 30% Solids	6956	06/04/2004	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	BRÒ 227A Primer	6957	06/16/2005	September 18, 2008
Cytec Industries Inc., West Paterson, New Jersey	BRÒ 1009-49 Tack Primer	6959	06/04/2004	September 18, 2008
Chevron Oronite Company LLC, Bellarie, Texas	OLOA 5653	6969	June 13, 2007	August 28, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTEÒ C-404	6971	5/15/2007	August 29, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMOHIBÒ 31	6972	5/15/2007	September 2, 2008
Cansolv Technologies Inc., Montréal, Québec	CANSOLV™ DC-103 A Solvent/SOLVANT CANSOLV™ DC-103 A	7034	2008-03-27	September 29, 2008
Cognis Canada Corporation, Mississauga, Ontario	WATERPOXY 751	7068	07/02/2007	September 19, 2008
Taminco Higher Amines Inc., Allentown, Pennsylvania	ADVANTEX (R)	7077	14 AUG 2006	September 2, 2008
Hexion Specialty Chemicals Inc., Houston, Texas	EPIKURE™ 3164 Curing Agent	7082	07/20/2007	September 29, 2008
Pulcra Chemicals LLC, Charlotte, North Carolina	KATAX 6660-A	7087	05/01/2008	September 3, 2008
Arkema Canada Inc., Oakville, Ontario	THERMOLITEÒ 380	7092	08/13/07	August 13, 2008
Taminco Higher Amines Inc., Allentown, Pennsylvania	VANTEXÒ T	7096	01/31/08	September 2, 2008
Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOLÒ 859	7113	23 August 2007	August 28, 2008
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	WITCONATE ™ AOS-12	7174	07/14/2008	September 22, 2008
Dow Chemical Canada Inc., Calgary, Alberta	CANSOLV (TM) Absorbent DM/ABSORBANT CANSOLV(MC) DM	7249	2008.02.28	September 4, 2008
Dow Chemical Canada Inc., Calgary, Alberta	TRITON(TM) DF-12 SURFACTANT/ Surfactif TRITON(MC) DF-12	7250	2008.04.01	September 17, 2008
Dow Chemical Canada Inc., Calgary, Alberta	UCARSOL(TM) HS SOLVENT 101/SOLVANT UCARSOL(MC) HS 101	7252	2008.02.21	September 4, 2008

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6236 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6284 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

3. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6496 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6533 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

5. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6535 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of one ingredient. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.

6. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6536 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of four ingredients. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.

7. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6537 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of five ingredients. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.

8. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6601 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

9. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6614 as EC3056A. The correct product identifier is FORTIS® EC3056A.

10. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6616 as Prism EC3264A. The correct product identifier is EC3264A.

11. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6651 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

12. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6698 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

13. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6729 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and the concentration of one ingredient.

14. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claims bearing Registry Numbers 6772, 6775 and 6776 to be the chemical identity of three ingredients. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of two, four and two ingredients, respectively.

15. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Numbers 6797 and 6798 to be the chemical identity of four ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.

16. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6800 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

17. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6821 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.

18. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Number 6857 and 6858 to be the chemical identity and the concentration of one ingredient. The subject of the claims on which the screening officer issued the decisions is the chemical identity of one ingredient.

19. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, listed the subject of the claim bearing Registry Number 6927 to be the chemical identity and the concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

20. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, incorrectly listed the subject of the claim bearing Registry Number 6950 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

21. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 7034 as CANSOLV™ DC-103 Solvent. The correct product identifier is CANSOLV™ DC-103 A Solvent.

There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the MSDSs in respect of which the claims bearing Registry Numbers 6564, 6592, 6593, 6595, 6596, 6599, 6609, 6614, 6615, 6616, 6697, 6722, 6735, 6736, 6742, 6743, 6746, 6779, 6783, 6809, 6817, 6853, 6859, 6864, 6871, 6887, 6969, 7113, 7249 and 7252 were filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claim bearing Registry Number 6533, being a claim from an employer in the province of Alberta, the screening officer found that the MSDS relating to this claim did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta.

In the case of the claims bearing Registry Numbers 6535, 6536 and 6537, being claims from an employer in the province of Alberta, the screening officer found that the MSDS in respect of which the claims were filed complied with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta while the labels in respect of which the claims were filed did not comply with the applicable disclosure requirements of the said act.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 6229

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of 2-butanone in the controlled product, its CAS Registry Number 78-93-3 and its percent concentration;

2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 300 ppm for 2-butanone.

Registry Number 6236

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose that the identity of ingredient acrylate binder is exempt from disclosure under HMIRC Registry Number 6236;

2. If 1,2,4-trimethylbenzene, naphthalene and ethylbenzene are disclosed on the MSDS, state that the ingredients are part of the complex mixture xylene;

3. Amend the first aid measures - Instructions for Eye Contact to advise that eyes should be flushed with large amounts of water for at least 20 minutes;

4. Amend the first aid measures - Instructions for Skin Contact subsection on the MSDS to state that skin should be flushed with large amounts of water for at least 20 minutes or until the chemical is removed. If breathing or the heart has stopped, trained personnel should immediately begin artificial respiration (AR) or cardiopulmonary resuscitation (CPR) respectively;

5. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;

6. Amend the MSDS to disclose the lower LC₅₀ (4 hours, rat) of 2 639 ppm for the hazardous ingredient cyclohexanone;

7. Amend the MSDS to disclose the lower LD₅₀ (oral, rat) value of 3 523 mg/kg for the hazardous ingredient xylene;

8. Amend the MSDS to correct the ACGIH exposure limits for the hazardous ingredient xylene;

9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 6284

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the identity and concentration of an additional ingredient with as much precision as possible;

2. Add instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 20 minutes or until the chemical is removed;

3. Add instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 20 minutes or until the chemical is removed;

4. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;

5. Amend the MSDS to disclose the ACGIH TLV–TWA exposure limit of 20 ppm for the hazardous ingredient toluene;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause colour vision loss;

7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause permanent hearing loss in laboratory animals;

9. Disclose that toluene is potentiated by acetylsalicylic acid and n-hexane to produce irreversible auditory damage in laboratory animals.

Registry Number 6419

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose an acceptable WEEL TWA of 50 ppm for the ingredient methoxy-2-propanol acetate;

2. Amend the MSDS to disclose that ingestion of an ingredient in the product has been known to cause central nervous system depression in laboratory animals.

Registry Number 6421

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose the appropriate concentration or concentration range for two ingredients in the controlled product;

2. Disclose the presence of 2-butanone in the controlled product, its CAS Registry Number 78-93-3 and its percent concentration;

3. Disclose the Exposure Limit Values ACGIH TLV–TWA = 200 ppm and ACGIH TLV–STEL = 300 ppm for 2-butanone.

Registry Numbers 6427 and 6428

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;

2. Disclose that an ingredient in the controlled product caused eye corrosion;

3. Modify the MSDS to disclose the statement or information similar to wash with soap and water for at least 30 minutes;

4. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting the claim bearing Registry Number 6427, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6456

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the identity of the three secret ingredients with as much precision as possible;

2. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product;

3. Disclose oral LD₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

4. Disclose an LC₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

5. If the WHMIS classification of the controlled product is disclosed on the MSDS, then the MSDS should be modified to disclose that the controlled product also has the D2A classification, in addition to the classes that are already disclosed.

Registry Number 6459

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product.

Registry Number 6496

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;

3. Add oxides of carbon and nitrogen to the list of hazardous combustion products;

4. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 6533

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the identity and concentration of an additional ingredient with as much precision as possible;

2. Amend the MSDS by removing the ACGIH TLV designation for nuisance dust;

3. Disclose an LD₅₀ value for the confidential hazardous ingredient in an acceptable manner.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6535

The claimant has been ordered to amend certain aspects of the content of the label.

In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been further ordered to amend the label as indicated below.

1. Disclose on the label that inhalation may cause central nervous system depression;

2. Modify the label to disclose the wash time of at least 30 min-utes applicable to cases of skin contact;

3. Modify the label to disclose the longer wash time of 30 minutes applicable to cases of eye contact;

4. Modify the label to disclose which specific personal protection equipment should be used e.g. glove type/material, goggles;

5. Modify the label to recommend to keep the product away from incompatibles such as strong oxidizing agents, strong bases, and acids.

Registry Number 6536

In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose information required by law pertaining to the progress of the claim for exemption on the label;

2. Disclose on the label that inhalation/ingestion may cause central nervous system depression and/or death;

3. Modify the label to disclose the wash time of at least 30 minutes applicable to cases of skin contact;

4. Modify the label to disclose the longer wash time of 30 minutes applicable to cases of eye contact;

5. Remove the statement “Have victim drink 2 glasses of water”;

6. Modify the label to disclose which specific personal protection equipment should be used, e.g. glove type/material, goggles;

7. Modify the label to recommend to keep the product away from incompatibles such as strong oxidizing agents, strong bases, and acids.

Registry Number 6537

In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been ordered to amend the label as indicated below.

1. Disclose information required by law pertaining to the progress of the claim for exemption on the label;

2. Disclose on the label that inhalation/ingestion may cause central nervous system depression and/or death;

3. Modify the label to disclose a wash time of at least 30 minutes applicable to cases of skin contact;

4. Modify the label to disclose a longer wash time of 30 minutes applicable to cases of eye contact;

5. Remove the statement “Have victim drink 2 glasses of water.”;

6. Modify the label to disclose which specific personal protection equipment should be used, e.g. glove type/material, goggles;

7. Modify the label to disclose that the product must be kept away from incompatible materials such as strong oxidizing agents, strong bases, and acids.

Registry Number 6556

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to clarify that the ingredient naphthalene is a component of the complex mixture solvent naphtha heavy aromatic;

2. Disclose the specific LD₅₀ (species and route) for a CBI ingredient;

3. Amend the MSDS to disclose that thermal decomposition of the controlled product releases oxides of sulfur;

4. Disclose that the TLV (ACGIH) of 0.2 ppm for the CBI ingredient is the time weighted average (TWA) value.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6557

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to clarify that the ingredient naphthalene is a component of an aromatic mixture;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;

3. Disclose the specific LD₅₀ (species and route) for a CBI ingredient;

4. Amend the MSDS to state a rinse time of at least 30 min or until the chemical is removed in the first aid advice for skin contact;

5. Amend the MSDS to state a rinse time of at least 30 min or until the chemical is removed in the first aid advice for eye contact;

6. To the first aid instructions, add a statement not to administer water unless under medical supervision. The advice to administer three to four glasses of liquid should be removed;

7. The MSDS should disclose that thermal decomposition of the controlled product releases oxides of carbon and oxide of sulfur.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6559

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the specific lower LD₅₀ (species and route) of 4 g/kg for ethylene glycol;

2. Disclose that ingestion of an ingredient in the controlled product has affected central nervous, respiratory, circulatory and urinary systems;

3. Disclose the ACGIH TLV–C = 100 mg/m³ value for the ingredient ethylene glycol;

4. Disclose the ACGIH TLV–TWA Exposure Limit Value for the confidential hazardous ingredient.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6561

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to clarify that the ingredients naphthalene and 1,2,3,4 trimethylbenzene are components of the solvent naphtha, petroleum heavy aromatic;

2. Disclose the CAS registry number, the chemical identity and concentration of an ingredient on the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6579

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.

Registry Number 6580

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.

Registry Number 6581

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.

Registry Number 6591

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of sulphur to the list of hazardous combustion products.

Registry Number 6601

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 6619

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Modify the MSDS to disclose the longer flush time of at least 30 minutes in the first aid advice for eye contact;

2. Modify the MSDS to disclose the statement or information similar to “Wash with soap and water for at least 30 minutes” in the case of first aid advice for skin contact.

Registry Number 6623

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose an acceptable chemical identity of an ingredient;

2. Amend the MSDS to disclose consistent information regarding the possible mutagenic effects of the controlled product.

Registry Number 6624

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of crystalline silica, quartz in the controlled product and its CAS Registry Number 14808-60-7;

2. Disclose an ACGIH TLV–TWA of 0.025 mg/m³ (respirable) for the hazardous ingredient crystalline silica;

3. Disclose that an ingredient in the controlled product has been classified as probably carcinogenic to humans (Group 2A) by the International Agency for Research on Cancer (IARC) and has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

4. Amend the MSDS to disclose consistent information regarding the possible mutagenic effects of the controlled product.

Registry Number 6628

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that ingestion of alcohol during pregnancy has caused birth defects in children;

2. Disclose that ingestion is a possible route of entry;

3. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;

4. Disclose an LC₅₀ (rat) value of 31 600 ppm for the ingredient ethanol;

5. Disclose that acute ingestion of an ingredient has caused gastric ulceration in laboratory animals;

6. Disclose that long-term ingestion of an ingredient has caused an increase of triglycerides in the plasma, liver and heart with atrophy of heart bundle muscle fibres, fragmentation and loss of striation in laboratory animals;

7. Disclose that an ingredient has produced mutagenic effects in germ cells and somatic cells in vivo;

8. Disclose that an ingredient has caused synergistic and potentiating effects with a wide range of industrial chemicals.

Registry Number 6630

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should not have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to remove the TWA (ACGIH) of 10 mg/m³ for total inhalable dust and 3 mg/m³ for respirable fraction for a particulate not regulated;

2. Disclose that skin irritation has been observed in laboratory animals as a result of dermal exposure to an ingredient in the controlled product.

Registry Number 6631

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to remove the TWA (ACGIH) of 10 mg/m³ for total inhalable dust and 3 mg/m³ for respirable fraction for a particulate not regulated.

Registry Number 6647

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the concentration of hazardous ingredients in acceptable ranges according to the CPR 11;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;

3. Disclose on the MSDS that hearing loss has been observed in laboratory animals as a result of inhalation of an ingredient in the controlled product;

4. Amend the MSDS to state an increased rinse time of at least 20 minutes or until the chemical is removed in the first aid advice for skin contact;

5. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;

6. Disclose on the MSDS that fetotoxic effects have been observed in animals as a result of inhalation of an ingredient during pregnancy;

7. Disclose that an ingredient in the controlled product has produced mutagenic effects in mammalian cells in vitro;

8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6651

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an acceptable chemical identity for a hazardous ingredient;

2. Add instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 20 minutes or until the chemical is removed;

3. Add instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 20 minutes or until the chemical is removed;

4. Add instructions similar to the following to the first aid measures - Instructions for Inhalation: If the heart has stopped, trained personnel should immediately begin cardio-pulmonary resuscitation (CPR);

5. Disclose the lower LC₅₀ (4 hours, female rat, vapour) of 19.0 mg/L for the hazardous ingredient toluene;

6. Amend the MSDS to correct the ACGIH exposure limit for the hazardous ingredient toluene and remove the skin notation;

7. Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause moderate irritation to the skin of laboratory animals;

8. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause colour vision loss;

10. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause hearing loss and altered immune function in laboratory animals;

11. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in yeast without metabolic activation, in vitro;

12. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in cultured mammalian cells, in vitro;

13. Amend the MSDS to disclose that an additional ingredient in the controlled product has been shown to cause birth defects or other reproductive harm;

14. Disclose that toluene is potentiated by acetylsalicylic acid and n-hexane to produce irreversible auditory damage in laboratory animals.

Registry Number 6653

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that ingestion of alcohol during pregnancy has caused birth defects in children;

2. Amend the MSDS to advise an increased rinse time of at least 30 minutes in the case of first aid advice for eye contact;

3. Amend the MSDS to incorporate an increased rinse time of at least 30 minutes in the case of first aid advice for skin contact;

4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;

5. Disclose that acute ingestion of alcohol has caused gastric ulceration in laboratory animals;

6. Disclose that long term ingestion of alcohol has caused an increase of triglycerides in the plasma, liver and heart in laboratory animals;

7. Disclose that ethanol has produced mutagenic effects in germ cells and somatic cells in vivo;

8. Disclose that ethanol has caused synergistic and potentiating effects with a wide range of industrial chemicals;

9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Numbers 6663 and 6664

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose a lower LD₅₀ value according to the regulations.

Registry Number 6671

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the identity, CAS registry number and concentration of another ingredient in the controlled product;

2. Disclose the current ACGIH TLV–TWA value of 200 ppm and the TLV–STEL of 250 ppm for an ingredient in the controlled product;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for 20 minutes or until the chemical is removed, contaminated clothing and footwear should be removed under running water, and medical advice should be obtained immediately;

4. Disclose LD₅₀ values for the confidential hazardous ingredient in an acceptable manner;

5. Disclose on the MSDS that an ingredient in the controlled product has produced fetotoxic and teratogenic effects and significant behavioural abnormalities in the offspring of experimental animals at dose levels not producing maternal toxic effects;

6. Disclose on the MSDS that an ingredient in the controlled product has tested positive in screening tests for mutagenicity with and without metabolic activation.

Registry Number 6672

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the ACGIH TLV–STEL value of 250 ppm for the ingredient methanol;

2. Amend the MSDS to disclose additional advice to specify a wash time of 20 minutes or until the chemical is removed and expand the advice to remove contaminated clothing, shoes and leather goods and obtain medical attention immediately, upon skin contact with the controlled product;

3. Disclose LD₅₀ values for the confidential hazardous ingredient in an acceptable manner;

4. Disclose on the MSDS that an ingredient in the controlled product causes mutagenic effects in animal and bacterial cells.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6681

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose the current exposure limits for these ingredients in the controlled product:

Xylene - ACGIH TLV–STEL - 150 ppm;

n-Amyl Acetate - ACGIH TLV–TWA - 50 ppm and ACGIH TLV–STEL 100 ppm;

Methanol - ACGIH TLV–STEL - 250 ppm;

Methyl Ethyl Ketone - ACGIH TLV–STEL - 300 ppm;

Isopropanol - ACGIH TLV–STEL - 400 ppm;

2. Amend the MSDS to disclose that the ACGIH TLV disclosed for the ingredient formaldehyde is a ceiling value;

3. Amend the MSDS to indicate that ethyl benzene is a part of the complex mixture xylene or remove the reference to ethyl benzene altogether;

4. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused CNS effects in male rabbits;

5. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused CNS effects, vision damage and gastrointestinal effects in humans;

6. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused acute renal failure in humans;

7. Disclose on the MSDS that acute ingestion of ingredients in the controlled product has caused lung damage, gastrointestinal, cardiovascular symptoms and CNS effects in humans;

8. Disclose on the MSDS that chronic inhalation exposure to an ingredient in the controlled product has caused lung fibrosis in animals;

9. Disclose on the MSDS that chronic inhalation exposure to an ingredient in the controlled product has caused hearing impairment in laboratory animals;

10. Amend the MSDS to advise a flush time of at least 30 minutes and to remove contaminated clothing, shoes and leather goods under running water in case of dermal contact with the controlled product;

11. Amend the MSDS to remove the instruction to induce vomiting by giving one tablespoon of syrup of ipecac or by sticking finger down throat, in case of ingestion of the controlled product;

12. Amend the MSDS to advise that if the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately; if breathing has stopped, trained personnel should administer artificial respiration immediately in case of ingestion of the controlled product and/or dermal contact in the case of methanol;

13. Add oxides of sulfur to the list of hazardous decomposition or combustion products;

14. Disclose the LD₅₀ (oral, rat) value of 2.51 g/kg for the ingredient n-butyl alcohol;

15. Disclose the LD₅₀ (oral, rat) value of 700 mg/kg for the ingredient n-amyl acetate;

16. Disclose the LD₅₀ (oral, rat) value of 3 523 mg/kg for the ingredient xylene;

17. Disclose the LD₅₀ (oral, rat) value of 2 900 mg/kg for the ingredient phenol-formaldehyde resin;

18. Disclose the LD₅₀ (oral, rat) value of 10 600 mg/kg for the ingredient ethanol;

19. Disclose the LD₅₀ (oral, rat) value of 13.0 mg/kg for the ingredient methanol;

20. Disclose the LD₅₀ (oral, rat) value of 530 mg/kg for the ingredient phenol;

21. Disclose the LD₅₀ (dermal, rabbit) value of 8 mL/kg for the ingredient isopropanol;

22. Disclose the LD₅₀ (dermal, male rabbit) value of 9.51 mL/kg for the ingredient n-amyl acetate;

23. Disclose the LD₅₀ (dermal, rabbit) value of 15 800 mg/kg for the ingredient methanol;

24. Disclose the LC₅₀ (4 hours, rat, vapour) value of 17 000 ppm for the ingredient isopropanol;

25. Disclose the LC₅₀ (4 hours, rat, vapour) value of 6 350 ppm for the ingredient xylene;

26. Disclose the LC₅₀ (4 hours, rat, vapour) value of 6 750 mg/m³ for the ingredient carbon black;

27. Disclose the LC₅₀ (4 hours, rat, vapour) value of 31 600 ppm for the ingredient ethanol;

28. Disclose the LC₅₀ (4 hours, rat, vapour) value of 11 300 ppm for the ingredient methyl ethyl ketone;

29. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects without maternal toxicity in laboratory animals;

30. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects with maternal toxicity in laboratory animals;

31. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects in human cells in vitro, in mammalian cells in vivo and in animal and bacterial cells;

32. Disclose on the MSDS the potentiation effects of n-hexane on the ingredient xylene to enhance hearing loss;

33. Disclose on the MSDS that the ingredient ethanol acts synergistically with trichloroethylene to reduce mental capacity and with N-butyraldoxime to cause CNS effects.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6684

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the current AIHA TWA exposure limit of 1 mg/m³ and the skin designation for the ingredient trimethylolpropane triacrylate;

2. Disclose that an ingredient in the controlled product is corrosive to the eyes of animals;

3. Disclose the LD₅₀ (oral, rat) value of 5.19 mL/kg for the ingredient trimethylolpropane triacrylate;

4. Disclose the LD₅₀ (dermal, rat) value of 6.35 mL/kg for the ingredient trimethylolpropane triacrylate;

5. Disclose the LC₅₀ (4 hours, rat) value of 33 mg/L for the ingredient 4-chlorobenzotrifluoride;

6. Disclose on the MSDS that ingredients in the controlled product have tested positive in screening tests for mutagenicity with and without metabolic activation.

Registry Number 6695

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose carbon, nitrogen and sulfur as hazardous combustion or decomposition products.

Registry Number 6698

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the concentrations of all hazardous ingredients in an acceptable WHMIS format;

2. Amend the instructions in the first aid measures - Skin Contact to state: If breathing has stopped, trained personnel should begin artificial respiration (AR) immediately. If the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately;

3. Amend the MSDS to disclose oxides of carbon as hazardous combustion products;

4. Disclose an LD₅₀ (oral, rat) value of 2.83 mL/kg (2.8 g/kg) and an LD₅₀ (dermal, rabbit) value of 0.56 mL/kg (550 mg/kg) for the first hazardous ingredient polyethylenepolyamine;

5. Disclose an LD₅₀ (oral, rat) value of 1.08 g/kg and an LD₅₀ (dermal, rabbit) value of 0.707 mL/kg (675 mg/kg) for the second hazardous ingredient polyethylenepolyamine.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6716

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an acceptable concentration ingredient range applies to stated concentration range of the hazardous ingredients cited in formulation of the controlled product.

Registry Number 6717

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose more specific chemical identities for three hazardous ingredients;

2. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 30 minutes;

3. Amend instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 30 minutes;

4. Add instructions similar to the following to the first aid measures - Instructions on Ingestion: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;

5. Disclose storage information similar to the following: Store in tightly closed, corrosion-resistant containers. Store in cool, dry, well ventilated areas, out of direct sunlight and away from sources of heat. Avoid rapid temperature changes;

6. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in cultured mammalian cells, in vitro;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 6729

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose acceptable information for the concentration of the CBI ingredient;

2. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give water to drink, if the victim is conscious;

3. Amend the MSDS to disclose as hazardous combustion products: oxides of carbon and nitrogen.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6740

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose on the MSDS that dermal exposure to an ingredient in the controlled product has caused liver necrosis;

2. Disclose that dermal application of an ingredient in the controlled product has caused a strong anaesthetic effect;

3. The specific first aid instruction to give two glasses of water should be removed from the MSDS;

4. Amend the MSDS to disclose oxides of carbon as hazardous combustion products;

5. Disclose the LD₅₀ values for the ingredient aliphatic C-8 ester according to the regulations;

6. Disclose the LC₅₀ values for the ingredient isoparaffinic hydrocarbon according to the regulations;

7. Disclose the LD₅₀ values for the ingredient benzyl alcohol according to the regulations.

Registry Number 6748

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of two additional confidential hazardous ingredients, along with their respective concentrations in an acceptable WHMIS format;

2. Disclose the ACGIH TLV–STEL exposure limit of 150 ppm for xylene;

3. Disclose the ACGIH TLV–TWA value of 200 ppm (skin) and the TLV–STEL value of 250 ppm (skin) for the hazardous ingredient methanol;

4. Disclose the ACGIH TLV–TWA value of 200 ppm and the TLV–STEL value of 400 ppm for the hazardous ingredient isopropanol;

5. Disclose the LD₅₀ (oral, male rat) value of 3 523 mg/kg for the hazardous ingredient xylene;

6. Disclose the LD₅₀ (oral, rat) value of 10 600 mg/kg for the hazardous ingredient ethanol;

7. Disclose an LC₅₀ (4 hours, rat) value of 6 350 ppm for the hazardous ingredient xylene;

8. Disclose an LC₅₀ (4 hours, rat) value for the hazardous ingredient ethanol;

9. Add the time frame of at least 15 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact;

10. Disclose that an ingredient of the controlled product has produced mutagenic effects in both germ and somatic cells of laboratory animals and has shown positive results in in vitro screening tests on human lymphocytes.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6749

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the ACGIH TLV–STEL exposure limit of 150 ppm for xylene;

2. Identify the disclosed exposure level limit for the confidential hazardous ingredient as being a ceiling limit and correct the information concerning the organization responsible for setting the limit;

3. Disclose the LD₅₀ (oral, male rat) value of 3 523 mg/kg and an LC₅₀ (4 hours, rat) value of 6 350 ppm for the hazardous ingredient xylene;

4. Disclose a dermal LD₅₀ value for the confidential ingredient;

5. Add the time frame of at least 30 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact;

6. Add oxides of nitrogen to the list of hazardous combustion products;

7. Disclose that an ingredient in the controlled product has produced fetal injury in laboratory animals;

8. If the WHMIS classification is going to be shown, add the classifications of Class D, Division 1, Subdivision A and Class D, Division 2, Subdivision A. Remove the existing Class B, Division 3 and add the classification Class B, Division 2.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6767

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose eye contact as a route of entry;

2. Amend instructions similar to the following to the first aid measures - After Skin Contact: Immediately flush with plenty of water for 20 minutes or until the chemical is removed;

3. Amend the MSDS to disclose oxides of nitrogen as hazardous combustion products;

4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 6770

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of methanol in the controlled product, its CAS Registry Number 67-56-1 and its percent concentration;

2. Disclose on the MSDS that an ingredient in the controlled product causes teratogenic/fetotoxic effects in the absence of maternal toxicity.

Registry Numbers 6771 and 6772

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 6774

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 6775

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 6776

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

3. Disclose on the MSDS that chronic exposure to an ingredient in the controlled product has caused kidney problems and testicular effects in laboratory animals;

4. Amend the MSDS to disclose the lower (oral, rat) LD₅₀ value of 340 mg/kg for the ingredient phenol.

Registry Number 6778

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to advise that if breathing has stopped, trained personnel should begin artificial respiration and if the heart has stopped, trained personnel should begin cardiopulmonary resuscitation, immediately, in case of skin contact with the controlled product;

2. Amend the MSDS to disclose the correct value of 1.18 g/mL at 25°C under the heading Specific Gravity/Density;

3. Disclose on the MSDS that an ingredient in the controlled product has shown mutagenic effects in mouse lymphoma cells;

4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

Registry Number 6780

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed.

Registry Number 6781

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous decomposition or combustion products.

Registry Number 6791

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose a lower LD₅₀ (oral, rat) value of 340 mg/kg for phenol.

Registry Number 6792

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose on the MSDS that an ingredient in the controlled product has the IARC Group 2B classification;

2. Disclose on the MSDS the current OSHA PEL value of 10 mg/m³ for the hazardous ingredient titanium dioxide.

Registry Numbers 6793 and 6794

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add HCl to the list of hazardous decomposition products;

2. Disclose on the MSDS that an ingredient in the controlled product has shown mutagenic effects in bacterial cells.

Registry Number 6795

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose the current TWA value of 1 mg/m³ for the ingredient aluminum.

Registry Numbers 6797and 6798

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add HCl to the list of hazardous combustion products;

2. Amend the MSDS to disclose the lower exposure limit of 0.025 mg/m³ for the ingredient silica, quartz.

Registry Number 6799

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose the appropriate concentration or concentration range for an ingredient in the controlled product;

2. Disclose on the MSDS the IARC 2B classification for the ingredient titanium dioxide.

Registry Number 6800

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose the appropriate concentration or concentration range for ingredients in the controlled product;

2. Disclose on the MSDS the IARC 2B classification for the ingredient titanium dioxide.

Registry Number 6809

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the section of the MSDS to also include oxides of nitrogen, hydrogen chloride and hydrogen cyanide as possible hazardous products of combustion;

2. Remove the TLV and TWA designations from the values disclosed on the MSDS as exposure limits for “particulates”.

Registry Number 6813

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6821

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of carbon to the list of hazardous combustion products.

Registry Numbers 6826 to 6831, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an accepted LD₅₀ value according to the regulations;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A;

3. Registry Number 6827:

(a) Disclose that eye corrosion has been observed in laboratory animals as a result of eye exposure to an ingredient in the controlled product;

(b) Amend the MSDS to disclose an increased rinse time of at least 30 minutes or until the chemical is removed in the first aid advice for eye contact.

4. Registry Numbers 6826 and 6828:

(a) Add oxides of nitrogen and chlorine to the list of hazardous decomposition or combustion products;

5. Registry Numbers 6827 and 6829:

(a) Add oxides of nitrogen to the list of hazardous decomposition or combustion products.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Numbers 6849 to 6851, inclusive

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose an ACGIH TLV–TWA of 1 mg/m³ (respirable) for the ingredient aluminum oxide;

2. Amend the MSDS to disclose an ACGIH TLV–TWA of 0.025 mg/m³ (respirable) for the hazardous ingredient cristabolite and the ACGIH A2 notation;

3. Amend the MSDS to disclose that the controlled product may be incompatible with the following materials: halocarbons, chlorine triflouride, ethylene oxide, oxygen diflouride and vinyl acetate.

Registry Number 6852

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add the time frame of 20 minutes to the rinsing recommendation for first aid measures in cases of eye contact.

Registry Number 6854

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous thermal decomposition products.

Registry Numbers 6857 and 6858

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an ACGIH TLV–STEL of 6 ppm (15 mg/m³) for the hazardous ingredient monethanolamine;

2. Disclose an AIHA WEEL of 10 ppm (8 hours) for the hazardous ingredient benzyl alcohol;

3. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the skin of laboratory animals;

4. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the eyes of laboratory animals;

5. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with water for at least 30 minutes;

6. Amend instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with water for at least 30 minutes;

7. Add instructions similar to the following to the first aid measures - Instructions on Ingestion: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration;

8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 6890

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the identity and concentration of a hazardous ingredient present at 0.7% weight/weight;

2. Disclose that ingestion of an ingredient in the controlled product has been shown to have teratogenic effects on laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6891

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6892 and 6893

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add the time frame of at least 30 minutes to the rinsing recommendation for first aid measures to be employed in cases of eye contact;

2. Add the time frame of at least 30 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Number 6899

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous decomposition products;

2. Amend the MSDS to disclose that the ingredient aromatic ketones has caused skin sensitization in laboratory animals.

Registry Number 6900

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush with plenty of water for at least 30 minutes.

Registry Number 6927

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give one or two glasses of water or milk.

Registry Number 6950

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of the ingredient which can be called phosphoric acid esters, amine salt and its concentration in an acceptable WHMIS format;

2. Report that oxides of nitrogen are also hazardous thermal decomposition products.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6955

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose on the MSDS the current ACGIH TLV–TWA value of 50 ppm and TLV–STEL of 100 ppm to the ingredient tetrahydrofuran;

2. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;

3. Amend the MSDS to disclose the correct value of the boiling point of the controlled product;

4. Amend the MSDS to disclose the correct value of the auto-ignition temperature of the controlled product;

5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 6956

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose on the MSDS the current ACGIH TLV–TWA value of 50 ppm and TLV–STEL of 100 ppm to the ingredient tetrahydrofuran;

2. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 6957

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of methanol in the controlled product, its CAS Registry Number 67-56-1 and its percent concentration;

2. Disclose on the MSDS the ACGIH TLV–TWA value of 20 ppm for the ingredient toluene with no skin notation;

3. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;

4. Amend the MSDS to state clearly what are the lower and upper flammable limits for the controlled product;

5. Disclose fumes of HCl as a hazardous combustion product;

6. Disclose on the MSDS that an ingredient in the controlled product causes teratogenic/fetotoxic effects in the absence of maternal toxicity;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 6959

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 6971

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 6972

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add HCl to the list of hazardous combustion products.

Registry Number 7034

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the skin of laboratory animals;

2. Amend the first aid measures - Swallowing subsection on the MSDS to add instructions similar to the following: If vomiting occurs naturally, lean the victim forward to reduce the risk of aspiration;

3. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 7068

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 7077

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend instructions to the first aid measures for eye contact to state: Immediately flush eyes with plenty of water for at least 30 minutes;

2. Amend instructions to the first aid measures for skin contact to state: Immediately flush eyes with plenty of water for at least 30 minutes;

3. Amend instructions to the first aid measures for ingestion to state: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration;

4. Amend the first aid measures pertaining to ingestion by deleting the statement to give water to drink;

5. Disclose an auto-ignition temperature of 340°C for the controlled product.

Registry Number 7082

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend instructions in the first aid measures - Eye Contact to state: Rinse immediately with plenty of water for at least 30 minutes;

2. Amend instructions in the first aid measures - Skin Contact to state: If breathing has stopped, trained personnel should begin artificial respiration (AR) immediately. If the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately;

3. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

4. Disclose an LD₅₀ value for another of the confidential hazardous ingredients in an acceptable manner;

5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 7087

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the MSDS to disclose an LD₅₀ (oral, rat) value for the controlled product with as much precision as possible.

Registry Number 7092

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 7096

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Amend the first aid measures - Ingestion by deleting the statement to give water to drink;

2. Amend instructions in the first aid measures - Eye contact to state: Immediately flush eyes with plenty of water for at least 30 minutes.

Registry Number 7174

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 7250

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 6533, 6535, 6536, 6537, 6564, 6592, 6593, 6595, 6596, 6599, 6609, 6614, 6615, 6616, 6697, 6722, 6735, 6736, 6742, 6743, 6746, 6779, 6783, 6809, 6817, 6853, 6859, 6864, 6871, 6887, 6969, 7113, 7249 and 7252, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

In the case of the claim bearing Registry Number 6533, the screening officer has ordered the claimant to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer, within the respective time period specified in the foregoing paragraph.

In the cases of the claims bearing Registry Numbers 6535, 6536 and 6537, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended label to the screening officer, within the respective time period specified in a foregoing paragraph.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-998-2363.

R. BOARDMAN
Chief Screening Officer